[ad_1]

An experimental treatment developed from cattle plasma for Middle East respiratory syndrome (MERS) coronavirus infection shows broad potential, according to a small clinical trial. The treatment, SAB-301, was safe and well tolerated by healthy volunteers, with only minor reactions documented.

[ad_2]

Source link

Agribusiness Information

LEAVE A REPLY

Please enter your comment!
Please enter your name here